Official SEC submissions

Mineralys Therapeutics SEC Filings

Direct answer

Mineralys Therapeutics's latest SEC filing is 4.

It was filed on August 25, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Mineralys Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

Verified data

Recent filing categories
4
Recent filings
40
SEC CIK
0001933414
Latest filing date
August 25, 2026

Explore related company data

View the Mineralys Therapeutics company profileView Mineralys Therapeutics annual financials